A lawsuit against pulse oximeter manufacturers and distributors is starting to create change. But experts say the FDA needs ...

The company added that the device will be indicated for both paroxysmal and persistent atrial fibrillation. Citing data from its PULSED AF study, Medtronic (MDT) said that the PulseSelect PFA ...

Medtronic and Recor Medical, Inc. (and its parent company, Otsuka Medical Devices Co., Ltd.) separately and independently ...

Medtronic announced new long-term data from the SPYRAL HTN-ON MED clinical trial of the company’s Symplicity Spyral renal ...

The Centers for Medicare & Medicaid Services granted transitional pass-through (TPT) payment status to Medtronic and Recor Medical for renal denervation devices to treat high blood pressure.